Atrial Fibrillation (AF) Clinical Trials in Houston, Texas

4 studies are recruiting for atrial fibrillation (af) in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

   This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can …

   Stage

   Phase 3

   Ages

   18 and older

   Site

   East Texas Cardiology, Houston, Texas

   Locations

   35 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT07430956 on ClinicalTrials.gov

2. Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

   This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. The aim of the study is to see how…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Synergy Groups Medical, Houston, Texas

   Locations

   32 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT07626411 on ClinicalTrials.gov

3. Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

   Heart failure and atrial fibrillation are two of the most common heart diseases globally. Nearly half of all patients with heart failure also have atrial fibrillation. When heart failure and atrial fibrillation occur together, the risk of hospitalization and premature death increases significantly.…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Methodist DeBakey Heart and Vascular Center, Houston, Texas

   Locations

   15 in total

   Run by

   Oslo University Hospital

   See if you can join NCT07436299 on ClinicalTrials.gov

4. Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

   A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.

   Stage

   Phase 3

   Ages

   65 and older

   Site

   Anthos Investigative Site 1068, Houston, Texas

   Locations

   789 in total

   Run by

   Anthos Therapeutics, Inc.

   See if you can join NCT05712200 on ClinicalTrials.gov